C-reactive protein is associated with sleep disordered breathing independent of adiposity

被引:172
作者
Punjabi, Naresh M. [1 ]
Beamer, Brock A. [1 ]
机构
[1] Johns Hopkins Univ, Dept Med, Baltimore, MD 21218 USA
关键词
sleep disordered breathing; obstructive sleep apnea; inflammation; C-reactive protein; NECROSIS-FACTOR-ALPHA; HORMONE REPLACEMENT THERAPY; CORONARY-HEART-DISEASE; LOW-GRADE INFLAMMATION; MENSTRUAL-CYCLE; CARDIOVASCULAR RISK; BODY-COMPOSITION; INTERLEUKIN-6; APNEA; MARKERS;
D O I
10.1093/sleep/30.1.29
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Study Objectives: It is well established that medical conditions such as obesity and cardiovascular disease are associated with increased levels of inflammatory biomarkers such as C-reactive protein (CRP). Prior studies have produced inconsistent results regarding the association between sleep disordered breathing (SDB) and CRP, possibly due to the confounding effects of obesity or medical comorbidity. The present study examined the association between degree of SDB and level of CRP independent of prevalent medical conditions and obesity. Design: Cross-sectional study. Subjects and Setting: University-based clinical sample referred for diagnostic polysomnography. Measurements and Results: The study sample consisted of 69 men (mean age 40 years; mean BMI of 31.2 kg/m(2)) free of prevalent medical conditions including hypertension, diabetes mellitus, and cardiovascular disease. Measurements of morning and evening CRP levels were performed along with full-montage polysomnography. Confounding due to obesity was assessed by adjustments for body mass index, waist circumference, and percent body fat. A strong association was found between degree of SDB and serum levels of CRP, with or without adjustment for age and several measures of adiposity. Between the lowest and highest quartiles of apnea-hypopnea index (AHI) the mean difference in adjusted level of CRP was 3.88 mu g/ml (P < 0.001). Moreover, an independent association between serum CRP levels and nocturnal hypoxia was also observed, whereas no association was noted with parameters of sleep architecture. Conclusions: While more research is needed to elucidate causal pathways involving the effects of sleep-related hypoxia on low-grade systemic inflammation, the results of this study suggest that mechanisms other than adiposity per se could contribute to the inflammatory state seen in adults with SDB.
引用
收藏
页码:29 / 34
页数:6
相关论文
共 56 条
[11]   Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians [J].
Forouhi, NG ;
Sattar, N ;
McKeigue, PM .
INTERNATIONAL JOURNAL OF OBESITY, 2001, 25 (09) :1327-1331
[12]   Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot difference and regulation by glucocorticoid [J].
Fried, SK ;
Bunkin, DA ;
Greenberg, AS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (03) :847-850
[13]   C-reactive protein and sleep-disordered breathing [J].
Guilleminault, C ;
Kirisoglu, C ;
Ohayon, MM .
SLEEP, 2004, 27 (08) :1507-1511
[14]   Cytokine response at high altitude: Effects of exercise and antioxidants at 4300 m [J].
Hagobian, TA ;
Jacobs, KA ;
Subudhi, AW ;
Fattor, JA ;
Rock, PB ;
Muza, SR ;
Fulc, CS ;
Braun, B ;
Grediagin, A ;
Mazzeo, RS ;
Cymerman, A ;
Friedlander, AL .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2006, 38 (02) :276-285
[15]  
Hartmann M, 2000, EUR J NEUROSCI, V12, P3
[16]   Hypoxia-sensitive molecules may modulate the development of atherosclerosis in sleep apnoea syndrome [J].
Hayashi, M ;
Fujimoto, K ;
Urushibata, K ;
Takamizawa, A ;
Kinoshita, O ;
Kubo, K .
RESPIROLOGY, 2006, 11 (01) :24-31
[17]  
Hori O, 1996, J NEUROCHEM, V66, P973
[18]   INCREASED ADIPOSE-TISSUE EXPRESSION OF TUMOR-NECROSIS-FACTOR-ALPHA IN HUMAN OBESITY AND INSULIN-RESISTANCE [J].
HOTAMISLIGIL, GS ;
ARNER, P ;
CARO, JF ;
ATKINSON, RL ;
SPIEGELMAN, BM .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (05) :2409-2415
[19]   The effects of hormone therapy on the markers of inflammation and endothelial function and plasma matrix metalloproteinase-9 level in postmenopausal women: The postmenopausal estrogen progestin intervention (PEPI) trial [J].
Hu, PF ;
Greendale, GA ;
Palla, SL ;
Reboussin, BA ;
Herrington, DM ;
Barrett-Connor, E ;
Reuben, DB .
ATHEROSCLEROSIS, 2006, 185 (02) :347-352
[20]   Evaluation of the novel Tanita body-fat analyser to measure body composition by comparison with a four-compartment model [J].
Jebb, SA ;
Cole, TJ ;
Doman, D ;
Murgatroyd, PR ;
Prentice, AM .
BRITISH JOURNAL OF NUTRITION, 2000, 83 (02) :115-122